NYSE - Delayed Quote USD

Alcon Inc. (ALC)

Compare
99.08 +0.31 (+0.31%)
At close: September 26 at 4:00 PM EDT
100.20 +1.12 (+1.13%)
Pre-Market: 8:44 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
9,636,000.00
9,455,000.00
8,717,000.00
8,291,000.00
6,833,000.00
--
Cost of Revenue
4,301,000.00
4,208,000.00
3,969,000.00
3,639,000.00
3,893,000.00
--
Gross Profit
5,335,000.00
5,247,000.00
4,748,000.00
4,652,000.00
2,940,000.00
--
Operating Expense
4,148,000.00
4,208,000.00
4,076,000.00
4,072,000.00
3,422,000.00
--
Operating Income
1,187,000.00
1,039,000.00
672,000.00
580,000.00
-482,000.00
--
Net Non Operating Interest Income Expense
-114,000.00
-155,000.00
-130,000.00
-127,000.00
-127,000.00
--
Other Income Expense
--
-52,000.00
-79,000.00
-35,000.00
-26,000.00
--
Pretax Income
1,021,000.00
832,000.00
463,000.00
418,000.00
-635,000.00
--
Tax Provision
-81,000.00
-142,000.00
128,000.00
42,000.00
-104,000.00
--
Net Income Common Stockholders
1,102,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Diluted NI Available to Com Stockholders
1,102,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Basic EPS
2.23
1.98
0.68
0.77
-1.09
--
Diluted EPS
2.22
1.96
0.68
0.76
-1.09
--
Basic Average Shares
493,650.00
493,000.00
491,400.00
490,000.00
489,000.00
--
Diluted Average Shares
496,900.00
496,500.00
494,400.00
493,400.00
489,000.00
--
Total Operating Income as Reported
1,187,000.00
1,039,000.00
672,000.00
580,000.00
-482,000.00
--
Total Expenses
8,449,000.00
8,416,000.00
8,045,000.00
7,711,000.00
7,315,000.00
--
Net Income from Continuing & Discontinued Operation
1,102,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Normalized Income
1,149,580.00
1,021,580.00
392,196.00
407,500.00
-509,264.00
--
Interest Income
--
45,000.00
16,000.00
3,000.00
6,000.00
--
Interest Expense
189,000.00
189,000.00
134,000.00
120,000.00
124,000.00
--
Net Interest Income
-114,000.00
-155,000.00
-130,000.00
-127,000.00
-127,000.00
--
EBIT
1,210,000.00
1,021,000.00
597,000.00
538,000.00
-511,000.00
--
EBITDA
2,439,000.00
2,242,000.00
1,720,000.00
1,757,000.00
1,112,000.00
--
Reconciled Cost of Revenue
4,301,000.00
4,208,000.00
3,969,000.00
3,639,000.00
3,893,000.00
--
Reconciled Depreciation
1,229,000.00
1,221,000.00
1,123,000.00
1,219,000.00
1,623,000.00
--
Net Income from Continuing Operation Net Minority Interest
1,102,000.00
974,000.00
335,000.00
376,000.00
-531,000.00
--
Total Unusual Items Excluding Goodwill
-52,000.00
-52,000.00
-79,000.00
-35,000.00
-26,000.00
--
Total Unusual Items
-52,000.00
-52,000.00
-79,000.00
-35,000.00
-26,000.00
--
Normalized EBITDA
2,491,000.00
2,294,000.00
1,799,000.00
1,792,000.00
1,138,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-4,420.00
-4,420.00
-21,804.00
-3,500.00
-4,264.00
--
12/31/2019 - 4/9/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
109.54
+1.04%
 
BLCO Bausch + Lomb Corporation
19.04
+0.11%
 
WST West Pharmaceutical Services, Inc.
307.14
+1.26%
 
BAX Baxter International Inc.
38.71
+0.97%
 
AVTR Avantor, Inc.
26.06
+1.52%
 
HOLX Hologic, Inc.
80.10
+0.30%
 
BDX Becton, Dickinson and Company
237.27
+0.88%
 
RMD ResMed Inc.
242.56
+0.75%
 
XRAY DENTSPLY SIRONA Inc.
26.51
+3.03%
 
AFX.DE Carl Zeiss Meditec AG
70.70
+7.28%